Official PBS account up $1.5b

Posted 19 January 2022 AM

The federal government has released its annual official rundown on PBS spending showing a rise of more than $1.5 billion in 2020-21 compared to the previous financial year with drugs from MSD, Vertex and BMS winning the biggest increases.

According to the PBS Expenditure and Prescriptions Report, government spending on Sections 85 and 100 of the Pharmaceutical Benefits Scheme increased nine per cent on an accrual accounting basis in the year to reach $13.75 billion (excluding revenue mostly from rebates) compared with $12.61 billion for the previous year. Patient contributions amounted to $1.5 billion.

To see the whole article, please login